Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (21)

2024

  1. Clearance of β-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

    GLIA, Vol. 72, Núm. 3, pp. 588-606

2023

  1. Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

2022

  1. Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance

    Autophagy, Vol. 17, Núm. 3, pp. 656-671

  2. Trehalose reduces the secreted beta-amyloid levels in primary neurons independently of autophagy induction

    Metabolites, Vol. 11, Núm. 7

2020

  1. Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease

    Frontiers in Synaptic Neuroscience, Vol. 12

2019

  1. Energy-sensing pathways in ischemia: The counterbalance between AMPK and mTORC

    Current Pharmaceutical Design, Vol. 25, Núm. 45, pp. 4763-4770

  2. Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain

    Frontiers in Aging Neuroscience, Vol. 11

2018

  1. Ovarian function modulates the effects of long-chain polyunsaturated fatty acids on the mouse cerebral cortex

    Frontiers in Cellular Neuroscience, Vol. 12

2017

  1. Assessment of autophagy in neurons and brain tissue

    Cells, Vol. 6, Núm. 3

  2. ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals

    Biomaterials, Vol. 112, pp. 141-152

2016

  1. AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging

    Journal of Alzheimer's Disease, Vol. 54, Núm. 2, pp. 645-656

  2. PTEN recruitment controls synaptic and cognitive function in Alzheimer's models

    Nature Neuroscience, Vol. 19, Núm. 3, pp. 443-453

  3. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 12, Núm. 1, pp. 43-52

2015

  1. HisAK70: Progress towards a vaccine against different forms of leishmaniosis

    Parasites and Vectors, Vol. 8, Núm. 1

  2. Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice

    Journal of Alzheimer's Disease, Vol. 44, Núm. 4, pp. 1063-1068

  3. Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 2, pp. 421-430

2014

  1. Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain

    Parasites and Vectors, Vol. 7, Núm. 1

2013

  1. Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer's disease

    Cellular and Molecular Life Sciences, Vol. 70, Núm. 15, pp. 2787-2797

2012

  1. Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: The role of the pathoantigenic HISA70 DNA vaccine

    Veterinary Research, Vol. 43, Núm. 1